Emerich Eichhorn - Concepedia

Author

Emerich Eichhorn

University of Regensburg

Also Known As

E Eichhorn, E. EICHHORN, E. Eichhorn, E. L. Eichhorn, Eichhorn, Emerich, Emerich Eichhorn

Publications

957

Citations

H-Index

Concepts

All Affiliations

University of Regensburg University of Tübingen Jena University Hospital Johannes Gutenberg University Mainz Osaka Institute of Technology

About

Emerich Eichhorn is an author at University of Regensburg specializing in chemistry, engineering, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	10	10	271
2	Medicine	6	6	306
3	Natural Sciences	6	6	172
4	Biochemistry	6	6	229
5	Biomolecular Engineering	1	1	90

Emerich Eichhorn

Publications

921

Citations

H-Index

Page 1

	Year	Citations
The crystal structure of cytosine-5-acetic acid R.E. Marsh, R. Bierstedt, Emerich Eichhorn Acta Crystallographica Crystal StructureBiochemistryProtein X-ray CrystallographyStructure ElucidationCrystallography	1962	99
Novel Chimeric Histone Deacetylase Inhibitors: A Series of Lapatinib Hybrides as Potent Inhibitors of Epidermal Growth Factor Receptor (EGFR), Human Epidermal Growth Factor Receptor 2 (HER2), and Histone Deacetylase Activity Siavosh Mahboobi, Andreas Sellmer, Mathias Winkler, Journal of Medicinal Chemistry Histone ModificationsChromatinMedicineHdac Inhibitory ActivityLapatinib Hybrides	2010	96
A macrocyclic [60]fullerene–porphyrin dyad involving π–π stacking interactions Elke Dietel, Andreas Hirsch, Emerich Eichhorn, Chemical Communications EngineeringPhotochemistryFullereneOrganic ChemistryChemistry	1998	91
Design of Chimeric Histone Deacetylase- and Tyrosine Kinase-Inhibitors: A Series of Imatinib Hybrides as Potent Inhibitors of Wild-Type and Mutant BCR-ABL, PDGF-Rβ, and Histone Deacetylases Siavosh Mahboobi, Stefan Dove, Andreas Sellmer, Journal of Medicinal Chemistry Histone DeacetylasesHdac InhibitorsTumor BiologyChimeric Histone Deacetylase-Anti-cancer Agent	2009	90
Marbostat-100 Defines a New Class of Potent and Selective Antiinflammatory and Antirheumatic Histone Deacetylase 6 Inhibitors Andreas Sellmer, Hubert Stangl, Mandy Beyer, Journal of Medicinal Chemistry	2018	77
3-Bromo-4-(1H-3-indolyl)-2,5-dihydro-1H-2,5-pyrroledione derivatives as new lead compounds for antibacterially active substances Siavosh Mahboobi, Emerich Eichhorn, Alfred Popp, European Journal of Medicinal Chemistry Derivative (Chemistry)Bioorganic ChemistryNatural SciencesOrganic ChemistryAntibacterial Agent	2006	51
Novel Bis(1<i>H</i>-indol-2-yl)methanones as Potent Inhibitors of FLT3 and Platelet-Derived Growth Factor Receptor Tyrosine Kinase Siavosh Mahboobi, Andrea Uecker, Andreas Sellmer, Journal of Medicinal Chemistry	2006	47
Electrochemistry of Oxygenation Catalysts. 3.<sup>1</sup> Thermodynamic Characterization of Electron Transfer and Solvent Exchange Reactions of Co(salen)/[Co(salen)]<sup>+</sup> in DMF, Pyridine, and Their Mixtures Emerich Eichhorn, Anton Rieker, Bernd Speiser, Inorganic Chemistry Formal Potentials EOxygen Reduction ReactionChemical EngineeringSolvent Exchange ReactionsEngineering	1997	43
On the structure of 4-nitropyridine-<i>N</i>-oxide Emerich Eichhorn Acta Crystallographica Inorganic ChemistryBiochemistryNatural SciencesChemistryInorganic Compound	1956	37
Chimerically designed HDAC- and tyrosine kinase inhibitors. A series of erlotinib hybrids as dual-selective inhibitors of EGFR, HER2 and histone deacetylases Thomas Beckers, Siavosh Mahboobi, Andreas Sellmer, MedChemComm Histone DeacetylasesTumor BiologyMolecular PharmacologyMedicinal ChemistryHistone Proteins	2012	35

Page 1